Sanofi/AVENTIS

Sanofi.com: Last press releases

Press releases and press packs are intended to journalists, investors and shareholders.

Genzyme’s Lemtrada Resubmission Accepted for Review by FDA

Posted: May 30, 2014, 6:15 am

Sanofi and Lilly announce licensing agreement for Cialis® (tadalafil) OTC

Posted: May 28, 2014, 4:00 am

Shantha’s Pentavalent Pediatric Vaccine prequalified by World Health Organization

Posted: May 5, 2014, 5:00 am

Annual General Shareholder Meeting of May 5, 2014

Posted: May 5, 2014, 4:15 am

Slowing of Brain Atrophy and Reductions in New Multiple Sclerosis Lesions Sustained at Three Years in Patients Treated with Genzyme’s Lemtrada

Posted: April 30, 2014, 2:30 am

Q1 2014 Business EPS up 5.8% at CER

Posted: April 29, 2014, 5:30 am

The World’s First, Large-Scale Dengue Vaccine Efficacy Study Successfully Achieved Its Primary Clinical Endpoint

Posted: April 28, 2014, 5:00 am

Sanofi Reaches New Milestone in Fight Against Malaria: 300 million ASAQ Treatments Delivered in Africa

Posted: April 25, 2014, 5:00 am

Genzyme to Resubmit Lemtrada™ Application for FDA Review

Posted: April 7, 2014, 5:00 am

Sanofi Appoints Dr. Anne C. Beal to the Newly Created Position of Chief Patient Officer

Posted: March 31, 2014, 5:00 am